Madrigal Pharmaceuticals, Inc. (MDGL) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "MDGL"
      ],
      "issuer_cik": "0001157601",
      "owner_cik": "0001518611",
      "accession_number": "0001628280-26-061581",
      "form_type": "4",
      "filing_date": "2026-09-11",
      "period_of_report": "2026-09-09",
      "issuer_name": "MADRIGAL PHARMACEUTICALS, INC.",
      "issuer_trading_symbol": "MDGL",
      "owner_name": "Sibold William John",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "President and CEO",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-09-11",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 218,
      "transaction_price_per_share": 535.9435,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 202583,
      "transaction_value": 116835.68299999999,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F16",
          "description": "These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026."
        },
        {
          "id": "F19",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.52 to $536.02, inclusive."
        }
      ]
    },
    {
      "tickers": [
        "MDGL"
      ],
      "issuer_cik": "0001157601",
      "owner_cik": "0001518611",
      "accession_number": "0001628280-26-061581",
      "form_type": "4",
      "filing_date": "2026-09-11",
      "period_of_report": "2026-09-09",
      "issuer_name": "MADRIGAL PHARMACEUTICALS, INC.",
      "issuer_trading_symbol": "MDGL",
      "owner_name": "Sibold William John",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "President and CEO",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-09-11",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 368,
      "transaction_price_per_share": 541.6423,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 201368,
      "transaction_value": 199324.3664,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F16",
          "description": "These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026."
        },
        {
          "id": "F22",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.00 to $541.73, inclusive."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.